Status:
COMPLETED
Endogenous Lithium Clearance in Acute Kidney Injury
Lead Sponsor:
University Hospital of North Norway
Conditions:
Acute Kidney Injury Due to Sepsis
Proximal Tubule Function
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides ...
Detailed Description
Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated.
Eligibility Criteria
Inclusion
- ICU patients diagnosed with AKI, without AKI and healthy controls
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05982340
Start Date
August 1 2023
End Date
May 20 2025
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Troms, Norway, 9038